The Impact of COVID-19 (SARS-CoV-2) has been detrimental worldwide. Insight Biotechnology offers a comprehensive catalogue of antibodies and reagents for COVID-19 research from outstanding suppliers. Furthermore, the outbreak has caused the existence of COVID-19 variants. We have sourced outstanding antibodies and reagents to combat the COVID-19 variants. Here at Insight, we have suppliers who provide COVID-19 rapid tests. We have the qRT-PCR, antigen and antibody test kits also available for your research.
Antibody screening has important public health uses in determining immunity to and prevalence of COVID-19, as well as identifying who has been infected and evaluating potential blood based therapeutics. Detect IgG, IgM, and IgA antibodies to SARS-CoV-2 N and S proteins using the indirect ELISA kits. Binding assays and pseudovirus services are available to determine if the antibodies present can inhibit cell binding, are neutralizing, or suitable for vaccine development.
SARS-CoV-2 antigen immunoassays test for the presence of viral proteins directly (unlike antibody tests, which detect an immune response to the virus). Highly sensitive ELISA and lateral flow assays are available for the nucleocapsid (N) and spike (S) proteins.
PCR kits allow rapid, convenient detection of SARS-CoV-2 nucleic acids. COVID-19 PCR kits are used for the direct detection of the viral RNA in saliva or nasopharyngeal swab samples. These tests are highly accurate, using methods that amplify nucleic acids, such as reverse transcription (RT) polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP).
Please click on the logo, for more info on the products offered by our suppliers to help you in your research in combating the COVID-19 disease.
Insight Biotechnology’s PhD level Technical Team is happy to help you identify and to discuss which COVID-19 products are suitable for your research. Contact us today by Telephone +44(0)20 8385 0303 or Email email@example.com